CA
SYRS

Centerpoint Advisors’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Centerpoint Advisors’s Portfolio SYRS Stock Details SYRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10,659
Closed -$2K – 480
2024
Q4 		$2K Hold
10,659
– – ﹤0.01% 418
2024
Q3 		$23K Buy
+10,659
New +$23K 0.01% 253